LUP Statistics
Record
- Title
- Divergence and convergence of commercial and scientific priorities in drug development: the case of Zelmid, the first SSRI antidepressant
- Type
- Journal Article
- Publ. year
- 2015
- Author/s
- Mulinari, Shai
- Department/s
- Department of Gender Studies
- In LUP since
- 2016-04-01
Downloads
Total | This Year | This Month |
530 | 36 | 1 |
United States of America | 242 (46%) |
Germany | 77 (15%) |
Sweden | 74 (14%) |
China | 30 (6%) |
United Kingdom of Great Britain and Northern Ireland | 18 (3%) |
Philippines | 9 (2%) |
Hong Kong (China) | 7 (1%) |
France | 6 (1%) |
Netherlands (Kingdom of the) | 5 (1%) |
Canada | 5 (1%) |
India | 5 (1%) |
Russian Federation | 4 (1%) |
Italy | 4 (1%) |
Ukraine | 3 (1%) |
Australia | 3 (1%) |
Colombia | 2 (0%) |
Ireland | 2 (0%) |
Cyprus | 2 (0%) |
Brazil | 2 (0%) |
South Korea | 2 (0%) |
Romania | 1 (0%) |
Macedonia | 1 (0%) |
Thailand | 1 (0%) |
Czechia | 1 (0%) |
Ethiopia | 1 (0%) |
Bulgaria | 1 (0%) |
Jordan | 1 (0%) |
Viet Nam | 1 (0%) |
Morocco | 1 (0%) |
Egypt | 1 (0%) |
Japan | 1 (0%) |
Unknown | 1 (0%) |
Pakistan | 1 (0%) |
United Arab Emirates | 1 (0%) |
Finland | 1 (0%) |
Portugal | 1 (0%) |
Denmark | 1 (0%) |
Saudi Arabia | 1 (0%) |
Spain | 1 (0%) |
Sri Lanka | 1 (0%) |
Bonaire, Sint Eustatius and Saba | 1 (0%) |